Loading...

Loading...

Study Shows Leqembi Cuts Cognitive Decline by 31%
By MBN Staff - Wed, 07/31/2024 - 17:22
Leqembi's data shows a 31% reduction in cognitive decline, with no new safety issues, contrasting with Lilly’s Kisunla in cost and approach.